Natasha Miley Email & Phone Number

Accountable for development and execution of operational strategy for Translational Medicine across Ophthalmology, Metabolism, Neuroscience & Immunology

Lead Alzheimer’s disease Alliance Planning Team creating the Commercial and Medical Affairs engagement strategy for professional societies, research organizations and non-profit advocacy. - Genentech lead for AAIC (Alzheimer's Association International Conference) including medical strategy, oversight of the medical agency vendor and coordinated planning between USMA, PDMA, US Commercial, and Global Product Strategy

Executed medical plans in support of scientific congresses for Multiple Sclerosis and Hemophilia, including direct oversight of medical agency vendors and coordinated planning between USMA, PDMA, US Commercial, and Global Product Strategy

Accountable for development and execution of operational strategy for the Biomarker Subteams including resource planning, operational alignment, and risk mitigation strategies. - Led operational biomarker strategy for the anti-PDL1 program, Genentech’s first cancer immunotherapy, including creation and leadership of weekly team alignment meetings for the 11 anti-PDL1 Biomarker Operations staff - Developed resourcing strategy for anti-PDL1 Biomarker Operations to support program growth 5 studies to 15 studies, which used close alignment, co-location and molecule focus to more efficiently resource an expansive clinical program - Matrix management, mentoring and onboarding of biomarker project managers for the anti-PDL1 program for >2 years, with positive progression by many staff including 2 contractor to permanent conversions and 2 promotions to Sr. Project Managers

Executed operational support to the Biomarker, Diagnostic, and Pharmacology Subteams as well as Study Management Teams by ensuring appropriate collection, delivery and analysis of biomarker (companion diagnostic and exploratory) and pharmacokinetic samples in clinical trials.

Bs

Ms